New study aims to spot heart trouble early in septic newborns
NCT ID NCT07572916
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will examine heart function in 80 newborns with sepsis using a special ultrasound (tissue Doppler echocardiography) and blood tests for cardiac troponin and other sepsis markers. The goal is to see if these tests can predict heart problems early. The study includes both preterm and term infants with confirmed sepsis, compared to healthy newborns.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors detect heart problems early in newborns with sepsis, potentially improving care and outcomes.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (80 participants) and not yet recruiting, so results may not apply broadly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEPSIS, MARKERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Medicine
Asyut, Egypt